Market Place
Sourcing Support
Axogen Reports 2025 Financial Results
24 Feb 2026 //
GLOBENEWSWIRE
Axogen to Participate in Multiple Upcoming Investor Conferences
17 Feb 2026 //
GLOBENEWSWIRE
Axogen to Report Q4, Full-Year 2025 Results on Feb. 24
10 Feb 2026 //
GLOBENEWSWIRE
Axogen Announces Proposed Public Offering Of Common Stock
21 Jan 2026 //
GLOBENEWSWIRE
Axogen Reports Preliminary Revenue For Q4 And Full-Year 2025
12 Jan 2026 //
GLOBENEWSWIRE
Axogen To Attend J.P. Morgan 2026 Healthcare Conference
17 Dec 2025 //
GLOBENEWSWIRE
FDA Approves Axogen`s Nerve Repair Graft
03 Dec 2025 //
PRESS RELEASE
Axogen Reports Third Quarter 2025 Financial Results
29 Oct 2025 //
GLOBENEWSWIRE
Axogen To Release 2025 Q3 Financial Results On October 29
15 Oct 2025 //
GLOBENEWSWIRE
Axogen to Attend Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Axogen Updates FDA Review Timeline for Avance Nerve Graft
25 Aug 2025 //
GLOBENEWSWIRE
Axogen Reports Second Quarter 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
Axogen, Inc. Joins Canaccord Genuity Annual Growth Conference
29 Jul 2025 //
GLOBENEWSWIRE
Axogen to Report 2025 Q2 Financial Results on August 5
22 Jul 2025 //
GLOBENEWSWIRE
Axogen at Goldman Sachs Global Healthcare Conference
28 May 2025 //
GLOBENEWSWIRE
Axogen Announces Chief Financial Officer Transition
08 May 2025 //
GLOBENEWSWIRE
Axogen Reports 2025 First Quarter Financial Results
08 May 2025 //
GLOBENEWSWIRE
Axogen, Inc. to report Q1 2025 financial results on May 8, 2025
24 Apr 2025 //
GLOBENEWSWIRE
Axogen appoints Rick Ditto as VP, Global Health Economics
24 Mar 2025 //
GLOBENEWSWIRE
Axogen, Inc. To Host Analyst & Investor Day on March 4th
25 Feb 2025 //
GLOBENEWSWIRE
Axogen to report 2024 Q4 & full year financial results on Feb 25
11 Feb 2025 //
GLOBENEWSWIRE
Axogen Announces Appointment of Jesse Bishop as Vice President
03 Feb 2025 //
GLOBENEWSWIRE
Axogen Reports Preliminary Revenue For Q4 And Full-Year 2024
10 Jan 2025 //
GLOBENEWSWIRE
Axogen Names New VP Of Operations & Announces Inducement Grant
10 Jan 2025 //
GLOBENEWSWIRE
Axogen, Inc Reports Q3 2024 Financial Results & BLA Update
07 Nov 2024 //
GLOBENEWSWIRE
Axogen To Report Q3 2024 Results On Nov 7, 2024
24 Oct 2024 //
GLOBENEWSWIRE
Axogen Reports Inducement Grant Under NASDAQ Rule 5635(c)(4)
03 Sep 2024 //
GLOBENEWSWIRE
Axogen, Inc. Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Axogen, Inc. Announces New Leadership Appointments
08 Aug 2024 //
GLOBENEWSWIRE
Axogen To Report Q2 2024 Results On August 8
23 Jul 2024 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Rule 5635(C)(4)
01 Jul 2024 //
GLOBENEWSWIRE
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
24 Jun 2024 //
GLOBENEWSWIRE
Axogen: Ohio Processing Center Opening Celebrated With State Leaders
28 May 2024 //
GLOBENEWSWIRE
Axogen Initiates Rolling BLA For Avance Nerve Graft
16 May 2024 //
GLOBENEWSWIRE
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
14 May 2024 //
GLOBENEWSWIRE
Axogen, Inc Reports First Quarter 2024 Financial Results
02 May 2024 //
GLOBENEWSWIRE
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix„
29 Apr 2024 //
GLOBENEWSWIRE
Axogen to Report Q1 2024 Results, Host Conference Call on May 2, 2024
16 Apr 2024 //
GLOBENEWSWIRE
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
05 Mar 2024 //
GLOBENEWSWIRE
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results
13 Feb 2024 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 Feb 2024 //
GLOBENEWSWIRE
Axogen, Inc. Announces Positive Topline Results from REPOSE
18 Jan 2024 //
GLOBENEWSWIRE
Axogen Announces Promotions on Research and Development Team
04 Jan 2024 //
GLOBENEWSWIRE
Axogen Announces Plan for Leadership Transition
04 Jan 2024 //
GLOBENEWSWIRE
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter & Full-Year 2023
04 Jan 2024 //
GLOBENEWSWIRE
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
26 Dec 2023 //
GLOBENEWSWIRE
Axogen Announces Transition of Finance Team Leadership
06 Dec 2023 //
GLOBENEWSWIRE
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 //
GLOBENEWSWIRE
Axogen to Participate at the Piper Sandler 35th Annual Healthcare Conference
20 Nov 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 Third Quarter Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Axogen, Inc. to Report Third Quarter 2023 Financial Results
18 Oct 2023 //
GLOBENEWSWIRE
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector„¢
05 Sep 2023 //
GLOBENEWSWIRE
Axogen to Participate at Upcoming Investor Conferences
31 Aug 2023 //
GLOBENEWSWIRE
Axogen Begins Processing Avance Nerve Graft at New Facility in Dayton
21 Aug 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 Second Quarter Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Axogen to Participate at Canaccord Genuity™s 43rd Annual Growth Conference
27 Jul 2023 //
GLOBENEWSWIRE
Axogen, Inc. to report second quarter 2023 financial results
26 Jul 2023 //
GLOBENEWSWIRE
Axogen to Participate at Jefferies Healthcare Conference
24 May 2023 //
GLOBENEWSWIRE
Axogen to Participate at JMP Securities Life Sciences Conference
12 May 2023 //
GLOBENEWSWIRE
Axogen, Inc. Reports 2023 First Quarter Financial Results
09 May 2023 //
GLOBENEWSWIRE
